CAPTRUST Financial Advisors
TARO

CAPTRUST Financial Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-58
Closed -$2K – 4293
2022
Q2 		$2K Hold
58
– – ﹤0.01% 4540
2022
Q1 		$3K Sell
58
-14
-19% -$654 ﹤0.01% 4412
2021
Q4 		$4K Sell
72
-1
-1% -$56 ﹤0.01% 4210
2021
Q3 		$5K Buy
73
+3
+4% +$208 ﹤0.01% 3973
2021
Q2 		$5K Sell
70
-3
-4% -$220 ﹤0.01% 3886
2021
Q1 		$5K Buy
+73
New +$5.54K ﹤0.01% 3757

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAPTRUST Financial Advisors's TARO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2022, closing a stake of 58 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in TARO in Q1 2021 and held it in 6 quarters. The position peaked at $5K in Q3 2021. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 58 Taro Pharmaceutical Industries Ltd. shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $5K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.